Get started
Author

Emmanuelle Weiller

Escitalopram Therapy for Major Depression and Anxiety Disorders
2007 · David S Baldwin, Elin Heldbo Reines, et al. · Annals of Pharmacotherapy · 228
Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
2016 · W. Wolfgang Fleischhacker, Mary Hobart, et al. · The International Journal of Neuropsychopharmacology · 91
PDF
Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder
2007 · Philip Gorwood, Emmanuelle Weiller, et al. · American Journal of Geriatric Psychiatry · 89
The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study
2016 · Leslie Citrome, Ai Ota, et al. · International Clinical Psychopharmacology · 76
Comorbidities in social phobia
1997 · Yves Lecrubier, Emmanuelle Weiller · International Clinical Psychopharmacology · 73
Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia
2016 · John M. Kane, Aleksandar Skuban, et al. · Schizophrenia Research · 69
PDF
Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 'With Mixed Features’ specifier
2013 · Thierry Hergueta, Emmanuelle Weiller · International Journal of Bipolar Disorders · 61
PDF
Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
2016 · Christoph U. Correll, Aleksandar Skuban, et al. · Schizophrenia Research · 60
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
2023 · Elias Wagner, Dan Siskind, et al. · Schizophrenia Bulletin · 50
PDF
Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials
2016 · Roger S. McIntyre, Emmanuelle Weiller, et al. · Journal of Affective Disorders · 37
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
2016 · Stephen R. Marder, Mika Juhani Hakala, et al. · Acta Neuropsychiatrica · 36
Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes: A Post Hoc Analysis
2015 · Michael Berk, John W. G. Tiller, et al. · The Journal of Clinical Psychiatry · 34
PDF
Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
2018 · Michael E Thase, Emmanuelle Weiller, et al. · Neuropsychiatric Disease and Treatment · 31
PDF
Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder
2018 · Rajnish Mago, Andrea Fagiolini, et al. · BMC Psychiatry · 31
PDF
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies
2018 · Catherine Weiss, Emmanuelle Weiller, et al. · International Clinical Psychopharmacology · 30
PDF
Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
2015 · Roger S. McIntyre, Emmanuelle Weiller · Advances in Therapy · 28
PDF
Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies
2018 · John W. Newcomer, Hans Eriksson, et al. · Current Medical Research and Opinion · 27
PDF
Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
2016 · Lori L. Davis, Ai Ota, et al. · Brain and Behavior · 25
PDF
Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
2016 · James Nelson, Peter Zhang, et al. · Current Psychiatry Reviews · 24
Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning
2016 · Maurizio Fava, Takao Okame, et al. · The International Journal of Neuropsychopharmacology · 23
PDF
The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study
2016 · Ashok Malla, Ai Ota, et al. · International Clinical Psychopharmacology · 23
Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies
2017 · J. Craig Nelson, Emmanuelle Weiller, et al. · Journal of Affective Disorders · 19
PDF
Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study
2016 · Jonas Eberhard, Emmanuelle Weiller · Neuropsychiatric Disease and Treatment · 18
PDF
Are old-old patients with major depression more likely to relapse than young-oldpatients during continuation treatment with escitalopram?
2011 · Constantine G Lyketsos, Emmanuelle Weiller, et al. · BMC Geriatrics · 18
PDF
Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study
2018 · Christoph U. Correll, Lily Shi, et al. · CNS Spectrums · 17
PDF
Works count: 52
Citation count: 1,341
H-index: 21
I10-index: 31
Year
Topic
Type